Neurones Management

How has Luc de Chammard's remuneration changed compared to Neurones's earnings?
Date	Total Compensation	Salary	Company Earnings
Jun 30 2024	n/a	n/a	€48m
Mar 31 2024	n/a	n/a	€49m
Dec 31 2023	€260k	€260k	€49m
Sep 30 2023	n/a	n/a	€49m
Jun 30 2023	n/a	n/a	€48m
Mar 31 2023	n/a	n/a	€46m
Dec 31 2022	€240k	€240k	€44m
Sep 30 2022	n/a	n/a	€43m
Jun 30 2022	n/a	n/a	€41m
Mar 31 2022	n/a	n/a	€40m
Dec 31 2021	€220k	€220k	€38m
Sep 30 2021	n/a	n/a	€37m
Jun 30 2021	n/a	n/a	€36m
Mar 31 2021	n/a	n/a	€33m
Dec 31 2020	€220k	€220k	€31m
Sep 30 2020	n/a	n/a	€30m
Jun 30 2020	n/a	n/a	€28m
Mar 31 2020	n/a	n/a	€30m
Dec 31 2019	€220k	€220k	€31m
Sep 30 2019	n/a	n/a	€30m
Jun 30 2019	n/a	n/a	€30m
Mar 31 2019	n/a	n/a	€28m
Dec 31 2018	€220k	€220k	€26m
Sep 30 2018	n/a	n/a	€26m
Jun 30 2018	n/a	n/a	€26m
Mar 31 2018	n/a	n/a	€27m
Dec 31 2017	€200k	€200k	€27m

Compensation vs Market: Luc's total compensation ($USD273.71K) is below average for companies of similar size in the French market ($USD853.23K).

Compensation vs Earnings: Luc's compensation has been consistent with company performance over the past year.

CEO

Luc de Chammard (70 yo)

39.9yrs

Tenure

€260,000

Compensation

Mr. Luc de Chammard serves as the Chairman, Chief Executive Officer and Chief Information Officer of Neurones S.A. and served as its Co-Chief Executive Officer. Mr. de Chammard has been a Director at Neuro...

Board Members

Name	Position	Tenure	Compensation	Ownership
Luc de Chammard	Chairman	39.9yrs	€260.00k	59.58% € 650.8m
Bertrand Ducurtil	COO, Executive VP	25.4yrs	€260.00k	4.15% € 45.3m
Hervé Pichard	Director	20.1yrs	€5.00k	0.00041% € 4.5k
Jean-Louis Pacquement	Independent Director	39.9yrs	€5.00k	0.000020% € 218.5
Marie-Françoise Jaubert	Independent Director	13.4yrs	€4.00k	0.00018% € 2.0k
Daphné de Chammard	Director	8.4yrs	€4.00k	0.025% € 274.2k
Emmanuelle Canza	Employee Representative Director	5.4yrs	no data	no data

20.1yrs

Average Tenure

69.5yo

Average Age

Experienced Board: NRO's board of directors are seasoned and experienced ( 20.1 years average tenure).

Neurones Management

Management criteria checks 3/4

Key information

Recent management updates

Less than half of directors are independent

Neurones S.A., Annual General Meeting, Jun 08, 2023

Less than half of directors are independent

What We Learned About Neurones' (EPA:NRO) CEO Pay

Recent updates

Neurones S.A. to Report First Half, 2025 Results on Sep 10, 2025

Now 21% undervalued after recent price drop

What Neurones S.A.'s (EPA:NRO) P/E Is Not Telling You

Upcoming dividend of €1.20 per share

Neurones S.A. Provides Earnings Guidance for the Year 2024

Dividend of €1.20 announced

Returns On Capital At Neurones (EPA:NRO) Have Hit The Brakes

Now 20% overvalued after recent price rise

Full year 2023 earnings released

Slowing Rates Of Return At Neurones (EPA:NRO) Leave Little Room For Excitement

Neurones S.A. to Report Fiscal Year 2023 Results on Mar 06, 2024

Neurones S.A. Provides Earnings Guidance for the Year 2023

Now 22% undervalued after recent price drop

Now 20% undervalued after recent price drop

First half 2023 earnings released

Neurones S.A. Provides Earnings Guidance for the Full Year 2023

Upcoming dividend of €1.10 per share at 2.8% yield

If EPS Growth Is Important To You, Neurones (EPA:NRO) Presents An Opportunity

Neurones S.A. Provides Earnings Guidance for the Full Year 2023

Full year 2022 earnings released

Neurones' (EPA:NRO) Returns Have Hit A Wall

Neurones S.A. to Report Fiscal Year 2022 Results on Mar 08, 2023

Price target increased to €44.33

Less than half of directors are independent

Neurones S.A., Annual General Meeting, Jun 08, 2023

Neurones S.A. to Report First Half, 2023 Results on Sep 06, 2023

Slowing Rates Of Return At Neurones (EPA:NRO) Leave Little Room For Excitement

Does Neurones (EPA:NRO) Deserve A Spot On Your Watchlist?

Neurones S.A. Confirms its Earnings Guidance for the Full Year 2022

First half 2022 earnings released

Neurones S.A. Provides Earnings Guidance for the Year 2022

Upcoming dividend of €1.00 per share

Neurones (EPA:NRO) Will Pay A Smaller Dividend Than Last Year

Full year 2021 earnings: Revenues in line with analyst expectations

Price target increased to €41.00

Less than half of directors are independent

Full year 2021 earnings: Revenues in line with analyst expectations

Should You Be Adding Neurones (EPA:NRO) To Your Watchlist Today?

Returns At Neurones (EPA:NRO) Appear To Be Weighed Down

Returns On Capital At Neurones (EPA:NRO) Paint A Concerning Picture

Upcoming dividend of €2.00 per share

Price target increased to €32.50

Price target increased to €31.00

Is Neurones S.A. (EPA:NRO) Trading At A 25% Discount?

Full year 2020 earnings released: EPS €1.28 (vs €1.27 in FY 2019)

Some Investors May Be Worried About Neurones' (EPA:NRO) Returns On Capital

Neurones S.A.'s (EPA:NRO) Stock's On An Uptrend: Are Strong Financials Guiding The Market?

Full year 2020 earnings released

Revenue beats expectations

The Neurones (EPA:NRO) Share Price Has Gained 54% And Shareholders Are Hoping For More

New 90-day high: €25.70

Price target raised to €29.00

Here's Why Neurones's (EPA:NRO) Statutory Earnings Are Arguably Too Conservative

Price target raised to €28.25

What Percentage Of Neurones S.A. (EPA:NRO) Shares Do Insiders Own?

Should Neurones S.A. (EPA:NRO) Be Part Of Your Dividend Portfolio?

New 90-day low: €23.00

Are Neurones S.A. (EPA:NRO) Investors Paying Above The Intrinsic Value?

What We Learned About Neurones' (EPA:NRO) CEO Pay

Investors Who Bought Neurones (EPA:NRO) Shares Five Years Ago Are Now Up 39%

Analysts increase EPS estimates to €1.12

Neurones S.A. to Report Fiscal Year 2020 Results on Mar 03, 2021

First half earnings released

New 90-day high - €25.60

Neurones (EPA:NRO) Is Growing Earnings But Are They A Good Guide?

CEO Compensation Analysis

CEO

Tenure

Compensation

Board Members

Average Tenure